Henning Willers
Papers
1
Total Citations
38
H-Index
1
About
Henning Willers is a leading radiation oncologist and translational researcher whose work bridges the molecular biology of cancer with precision radiotherapy. His research centers on DNA damage repair, genomic biomarkers, and the development of molecularly targeted radiosensitizers. A key contribution is his pioneering effort to adapt large-scale drug screening platforms—traditionally used for chemotherapy agents—to identify associations between targeted radiosensitizers and specific genomic alterations in cancer cells. His 2015 paper on this approach, which has garnered 38 citations, demonstrates how annotated cancer cell line collections can uncover predictive biomarkers for combining radiotherapy with molecular therapies. This work has significant implications for personalizing radiation treatment, moving beyond one-size-fits-all approaches. Willers’ research is notable for its translational focus, aiming to directly inform clinical trial design by matching patients’ tumor genetics with the most effective radiosensitizing drugs. His contributions are shaping the future of precision radiation oncology, offering a roadmap to improve therapeutic ratios and outcomes for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1